[ 메디채널 김갑성 기자 ] SAN FRANCISCO and SUZHOU, China, July 17, 2025 -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announced that Nature Medicine (IF: 58.7) has published the results of the Phase 1 clinical study of IBI343, an innovative anti-CLDN18.2 ADC, for the treatment of advanced gastric/gastroesophageal junction (G/GEJ) adenocarcinoma[Link]. Publicati
STUART, Fla., July 17, 2025 -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is proud to announce its financial support for Community Foster Closet, a local nonprofit in Spokane Valley, Washington, dedicated to providing free clothing, shoes, diapers, wipes, and other essentials to foster families within the community. Since its opening in October 2023, the Community Foster Closet has helped over 100 families and provided vital support to more than 370 children with critical resources. Operated entirely through d
AUSTIN, Texas, July 16, 2025 -- FlatTech LLC, doing business as Flat Medical today announced that it was honored during Premier, Inc.'s annual supplier Innovation Celebration at the 2025 Breakthroughs Conference and Exhibition. The Innovation Celebration recognizes groundbreaking healthcare technologies that have been launched throughout the year and the ways these products are helping to improve the health of communities. About the EpiFaith Smart Syringe The EpiFaith Smart Syringe transforms traditional epidural procedures by converting the tactile loss-of-resistance technique
In a world where delays cost millions, this AI copilot shows teams what's changing, what to do, and what happens next. LOS ANGELES, July 16, 2025 -- Rwazi has raised $12 million in Series A funding to replace every gut call with an AI copilot. The round will accelerate development of its simulation engine and decision copilot — giving teams real-time visibility into what's changing, what to do next, and what outcome to expect. "For decades, decisions have been driven by instinct. But gut calls are expensive — and in today's market, they're dangerous,"
지연이 수백만 달러의 손실로 이어지는 시대, 이 AI 코파일럿은 팀에게 무엇이 변하고 있는지, 무엇을 해야 하는지, 그리고 그 결과가 어떻게 될지를 실시간으로 보여준다. 로스앤젤레스, 2025년 7월 16일 -- Rwazi가 '감에 의존한 결정'을 대체하는 AI 코파일럿 개발을 위해 시리즈 A(Series A) 펀딩으로 미화 1200만 달러를 유치했다. 이번 투자금은 시뮬레이션 엔진 및 의사 결정 코파일럿 개발 가속화에 사용되며, 이를 통해 팀들이 실시간으로 변경 사항, 대응 전략, 예상 결과까지 가시화할 수 있도록 지원한다. 조셉 루타캉와 (Joseph Rutakangwa) Rwazi 공동 창업자 겸 최고경영자(CEO)는 "수십 년 동안 기업 의사결정은 '감'에 의존해 왔지만, 이런 결정은 비용이 많이 들고, 현재 시장 환경에서는 위험하기까지 하다"며 "이번 투자 유치를 통해 모든 의사결정자에게 실시간 AI 코파일럿을 제공함으로써, 팀이 더 빠르고 더 스마트하며 확신을 가지고 움직일 수 있게 만들 것"이라고 말했다. 대부분의 AI 시스템이 스크랩된
SEONGNAM, South Korea, July 16, 2025 -- In a strong endorsement of its cutting-edge drug delivery technology, SN BioScience announced that its anticancer candidate SNB-101 has been selected as a clinical-stage project under the 2025 Korea Drug Development Project, a government-initiated program led by the Korea Drug Development Fund (KDDF). The program includes two years of research support, aiding the company's advancement of SNB-101 into global Phase 1b/2 trials. The Korea Drug Development Fund (KDDF) is a government agency funded by three ministries. It aims to actively fund and pro
SHENZHEN, China, July 16, 2025 -- Under the guidance of UNESCO and the United Nations International Cooperation Public Welfare Organization, the 2025 Mammoth International Contest on Omics Sciences - Young Scientist Track (referred to as 2025 MICOS-Youth), co-organized by BGI Research and Jinze Charitable Foundation, was officially launched on May 22, 2025. About the Competition Previously, the Mammoth Cup had held four successful competitions with the focus on cutting-edge life science research and industry innovation. This year, the 5th edition of Mammoth Cup launched with a n
SHENZHEN, China, July 16, 2025 -- Huawei held the 2025 Global Education and Healthcare Partner China Convention. Over 300 partner guests from 40 countries attended. At the event, Huawei launched the Global Education and Healthcare Partner Alliance (GEHPA). This initiative aims to strengthen communication with industry partners, leverage mutual strengths, achieve win-win cooperation, and ultimately build a high-quality, sustainable industry ecosystem. Members of the alliance can jointly undertake technical research and develop innovative solutions to power the digital transformation of educati
[ 메디채널 김갑성 기자 ] Best ESG rating tier of negligible-risk with a top 1% global ranking score Industry and Regional ESG Top-Rated Company for five consecutive years Leader in Green CRDMO to drive innovation for a healthier future SHANGHAI, July 16, 2025 -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has elevated its Morningstar Sustainalytics ESG rating score to the highest negligible-risk tier, demonstrating its leadership in the global pharmaceutical industry. Sustainalytics is a lea
SHENZHEN, China, July 16, 2025 -- Huawei held the 2025 Global Education and Healthcare Partner China Convention. Over 300 partner guests from 40 countries attended. At the event, Huawei launched the Global Education and Healthcare Partner Alliance (GEHPA). This initiative aims to strengthen communication with industry partners, leverage mutual strengths, achieve win-win cooperation, and ultimately build a high-quality, sustainable industry ecosystem. Members of the alliance can jointly undertake technical research and develop innovative solutions to power the digital transformation of educati